Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 15 Artikel )

12.10.2018 | Original Article | Ausgabe 2/2019 Open Access

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade

Hanna Grauers Wiktorin, Malin S. Nilsson, Roberta Kiffin, Frida Ewald Sander, Brianna Lenox, Anna Rydström, Kristoffer Hellstrand, Anna Martner

17.10.2018 | Original Article | Ausgabe 2/2019

The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth

Tyler R. McCaw, Mei Li, Dmytro Starenki, Sara J. Cooper, Mingyong Liu, Selene Meza-Perez, Rebecca C. Arend, Donald J. Buchsbaum, Andres Forero, Troy D. Randall

19.10.2018 | Original Article | Ausgabe 2/2019

INT-HA induces M2-like macrophage differentiation of human monocytes via TLR4-miR-935 pathway

Boke Zhang, Yan Du, Yiqing He, Yiwen Liu, Guoliang Zhang, Cuixia Yang, Feng Gao

24.10.2018 | Original Article | Ausgabe 2/2019

Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment

Daisuke Umezu, Nana Okada, Yukimi Sakoda, Keishi Adachi, Toshiyasu Ojima, Hiroki Yamaue, Masatoshi Eto, Koji Tamada

25.10.2018 | Original Article | Ausgabe 2/2019

Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma

Jacqueline E. Mann, Joshua D. Smith, Andrew C. Birkeland, Emily Bellile, Paul Swiecicki, Michelle Mierzwa, Steven B. Chinn, Andrew G. Shuman, Kelly M. Malloy, Keith A. Casper, Scott A. McLean, Jeffery S. Moyer, Gregory T. Wolf, Carol R. Bradford, Mark E. Prince, Thomas E. Carey, Jonathan B. McHugh, Matthew E. Spector, J. Chad Brenner

25.10.2018 | Original Article | Ausgabe 2/2019

Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis

Yi-hui Wen, Han-qing Lin, Hang Li, Yi Zhao, Vivian Wai Yan Lui, Lin Chen, Xing-mei Wu, Wei Sun, Wei-ping Wen

31.10.2018 | Original Article | Ausgabe 2/2019

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

Laura A. Vitale, Lawrence J. Thomas, Li-Zhen He, Thomas O’Neill, Jenifer Widger, Andrea Crocker, Karuna Sundarapandiyan, James R. Storey, Eric M. Forsberg, Jeffrey Weidlick, April R. Baronas, Lauren E. Gergel, James M. Boyer, Crystal Sisson, Joel Goldstein, Henry C. Marsh Jr., Tibor Keler

07.11.2018 | Original Article | Ausgabe 2/2019 Open Access

The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design

Matthieu Besneux, Alexander Greenshields-Watson, Martin J. Scurr, Bruce J. MacLachlan, Adam Christian, Michael M. Davies, Rachel Hargest, Simon Phillips, Andrew Godkin, Awen Gallimore

07.11.2018 | Original Article | Ausgabe 2/2019

Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer

Wenli Yuan, Deyao Deng, Hongchao Jiang, Changling Tu, Xueqin Shang, Hongchun He, Ruize Niu, Jian Dong

14.11.2018 | Original Article | Ausgabe 2/2019

Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly

Wagner A. Poles, Erika E. Nishi, Mariana B. de Oliveira, Angela I. P. Eugênio, Tathiana A. de Andrade, Antonio Hugo F. M. Campos, Ruy R. de Campos Jr., José Vassallo, Antonio C. Alves, Cristovam Scapulatempo Neto, Roberto Antonio Pinto Paes, Gilles Landman, Maria Cláudia N. Zerbini, Gisele W. B. Colleoni

17.11.2018 | Original Article | Ausgabe 2/2019

Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers

Shu-Fen Chiang, Chih-Yang Huang, Tao-Wei Ke, Tsung-Wei Chen, Yu-Ching Lan, Ying-Shu You, William Tzu-Liang Chen, K. S. Clifford Chao

26.11.2018 | Original Article | Ausgabe 2/2019

Can benign lymphoid tissue changes in 18F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?

Christos Sachpekidis, Lionel Larribère, Annette Kopp-Schneider, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss

27.11.2018 | Original Article | Ausgabe 2/2019

Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma

Soo Jeong Nam, Young-Hoon Kim, Ji Eun Park, Young-shin Ra, Shin Kwang Khang, Young Hyun Cho, Jeong Hoon Kim, Chang Ohk Sung

09.11.2018 | Clinical Trial Report | Ausgabe 2/2019 Open Access

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma

Charlotte M. Huijts, Inge M. Werter, Sinéad M. Lougheed, Ruben S. Goedegebuure, Carla M. van Herpen, Paul Hamberg, Metin Tascilar, John B. Haanen, Henk M. Verheul, Tanja D. de Gruijl, Hans J. van der Vliet, for the Dutch WIN-O Consortium

14.11.2018 | Clinical Trial Report | Ausgabe 2/2019 Open Access

A phase I clinical study of a cocktail vaccine of Wilms’ tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma

Akihiro Tsuboi, Naoya Hashimoto, Fumihiro Fujiki, Soyoko Morimoto, Naoki Kagawa, Hiroko Nakajima, Naoki Hosen, Sumiyuki Nishida, Jun Nakata, Satoshi Morita, Junichi Sakamoto, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise